GlassScriptPhysician profile
James K Mcgraw
NPI 1700865896
$222,351.89
in general payments reported to CMS, 2019-2025
10 companies · $38K in 2025
The $38K reported for 2025 was more than what 96% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $25K · 2021: $25K · 2022: $36K · 2023: $36K · 2024: $37K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $108K · Long Term Medical Supply Or Device Loan: $2,556 · Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $108,000.00 |
| Long Term Medical Supply Or Device Loan | $2,555.56 |
| Food and Beverage | $421.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clinical Technology, INC | $218,999.88 | 2019-2025 | Pain Management |
| Angiodynamics, INC. | $2,573.51 | 2023-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Stryker Corporation | $236.83 | 2021-2024 | Spinejack |
| Lenoss Medical INC | $113.75 | 2024 | Access & Cavity Creation Kit |
| Penumbra, INC. | $110.13 | 2019 | |
| Advanced Critical Devices, INC. | $91.68 | 2022 | |
| Medtronic, INC. | $89.53 | 2021-2023 | Abre |
| Boston Scientific Corporation | $50.25 | 2024-2025 | Varithena Administration Pack |
| Abbott Laboratories | $44.03 | 2023-2025 | Viewmate |
| Medtronic Vascular, INC. | $42.30 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$23,836.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcgraw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.